华邦健康
(002004)
| 流通市值：72.65亿 | | | 总市值：76.42亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,909,836,679.88 | 5,922,042,354.85 | 2,915,489,646.11 | 11,594,590,416.29 |
| 营业收入 | 8,909,836,679.88 | 5,922,042,354.85 | 2,915,489,646.11 | 11,594,590,416.29 |
| 二、营业总成本 | 8,114,670,346.58 | 5,370,629,390.07 | 2,650,059,150.01 | 10,449,043,844.97 |
| 营业成本 | 5,629,798,504.13 | 3,747,661,339.12 | 1,859,121,218.49 | 7,059,524,428.96 |
| 税金及附加 | 98,976,738.22 | 65,451,526.03 | 31,351,149 | 132,886,751.3 |
| 销售费用 | 896,944,174.99 | 635,971,224.06 | 294,092,872.88 | 1,303,313,307.66 |
| 管理费用 | 953,561,648.45 | 591,833,633.24 | 295,906,066.31 | 1,303,404,018.21 |
| 研发费用 | 301,716,088.01 | 190,304,390.17 | 94,529,223.4 | 419,138,741.86 |
| 财务费用 | 233,673,192.78 | 139,407,277.45 | 75,058,619.93 | 230,776,596.98 |
| 其中:利息费用 | 263,838,241.88 | 177,477,703.22 | 87,226,372.8 | 343,699,597.7 |
| 其中:利息收入 | 48,493,362.3 | 35,168,704.15 | 16,861,520.12 | 85,226,254.42 |
| 加:公允价值变动收益 | 922,533.86 | -169,375.24 | 1,075,308.34 | 1,199,227.48 |
| 加:投资收益 | -50,134,221.39 | -11,733,497.63 | 6,458,725.6 | 7,521,394.86 |
| 资产处置收益 | 3,888,656.97 | 3,814,784.27 | 310,665.72 | 28,111,567.86 |
| 资产减值损失(新) | -16,310,776.11 | -11,745,270.41 | 39,596.96 | -380,091,090.99 |
| 信用减值损失(新) | -6,869,990.29 | -4,786,957.99 | -277,979.25 | -2,347,194.66 |
| 其他收益 | 57,424,963.96 | 35,551,029.03 | 12,737,122.18 | 126,570,747.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 784,087,500.3 | 562,343,676.81 | 285,773,935.65 | 926,511,223.44 |
| 加:营业外收入 | 6,690,304.94 | 4,902,193.38 | 1,982,696.92 | 12,477,491.2 |
| 减:营业外支出 | 22,332,641.06 | 13,024,749.57 | 4,178,033.46 | 46,601,131.44 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 768,445,164.18 | 554,221,120.62 | 283,578,599.11 | 892,387,583.2 |
| 减:所得税费用 | 183,328,358.37 | 130,012,257.75 | 69,149,676.73 | 215,455,687.83 |
| 六、净利润 | 585,116,805.81 | 424,208,862.87 | 214,428,922.38 | 676,931,895.37 |
| 持续经营净利润 | 585,116,805.81 | 424,208,862.87 | 214,428,922.38 | 676,931,895.37 |
| 归属于母公司股东的净利润 | 451,977,453.17 | 313,522,665.65 | 155,559,826.48 | 302,122,026.53 |
| 少数股东损益 | 133,139,352.64 | 110,686,197.22 | 58,869,095.9 | 374,809,868.84 |
| (一)基本每股收益 | 0.23 | 0.16 | 0.08 | 0.15 |
| (二)稀释每股收益 | 0.23 | 0.16 | 0.08 | 0.15 |
| 八、其他综合收益 | -69,850,813.11 | -32,383,081.04 | -7,790,298.79 | 16,577,062.77 |
| 归属于母公司股东的其他综合收益 | -33,462,126.23 | -15,688,757.44 | -3,992,417.2 | 6,289,571.33 |
| 九、综合收益总额 | 515,265,992.7 | 391,825,781.83 | 206,638,623.59 | 693,508,958.14 |
| 归属于母公司股东的综合收益总额 | 418,515,326.94 | 297,833,908.21 | 151,567,409.28 | 308,411,597.86 |
| 归属于少数股东的综合收益总额 | 96,750,665.76 | 93,991,873.62 | 55,071,214.31 | 385,097,360.28 |
| 公告日期 | 2024-10-29 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |